203 related articles for article (PubMed ID: 34792662)
1. Cross-comparison of systemic and tissue-specific metabolomes in a mouse model of Leigh syndrome.
Terburgh K; Lindeque JZ; van der Westhuizen FH; Louw R
Metabolomics; 2021 Nov; 17(12):101. PubMed ID: 34792662
[TBL] [Abstract][Full Text] [Related]
2. Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.
Johnson SC; Kayser EB; Bornstein R; Stokes J; Bitto A; Park KY; Pan A; Sun G; Raftery D; Kaeberlein M; Sedensky MM; Morgan PG
Mol Genet Metab; 2020 Jun; 130(2):118-132. PubMed ID: 32331968
[TBL] [Abstract][Full Text] [Related]
3. Aberrant BCAA and glutamate metabolism linked to regional neurodegeneration in a mouse model of Leigh syndrome.
Terburgh K; Coetzer J; Lindeque JZ; van der Westhuizen FH; Louw R
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166082. PubMed ID: 33486097
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics of Ndufs4
Terburgh K; Lindeque Z; Mason S; van der Westhuizen F; Louw R
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):98-106. PubMed ID: 30391276
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia ameliorates brain hyperoxia and NAD
Grange RMH; Sharma R; Shah H; Reinstadler B; Goldberger O; Cooper MK; Nakagawa A; Miyazaki Y; Hindle AG; Batten AJ; Wojtkiewicz GR; Schleifer G; Bagchi A; Marutani E; Malhotra R; Bloch DB; Ichinose F; Mootha VK; Zapol WM
Mol Genet Metab; 2021 May; 133(1):83-93. PubMed ID: 33752971
[TBL] [Abstract][Full Text] [Related]
6. Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome.
Aguilar K; Comes G; Canal C; Quintana A; Sanz E; Hidalgo J
Glia; 2022 Nov; 70(11):2032-2044. PubMed ID: 35770802
[TBL] [Abstract][Full Text] [Related]
7. Targeting NAD
Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
[TBL] [Abstract][Full Text] [Related]
8. Miniaturized
Mason S; Terburgh K; Louw R
Metabolomics; 2018 May; 14(6):74. PubMed ID: 30830372
[TBL] [Abstract][Full Text] [Related]
9. Sub-Cellular Metabolomics Contributes Mitochondria-Specific Metabolic Insights to a Mouse Model of Leigh Syndrome.
van der Walt G; Lindeque JZ; Mason S; Louw R
Metabolites; 2021 Sep; 11(10):. PubMed ID: 34677373
[TBL] [Abstract][Full Text] [Related]
10. Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain.
Kayser EB; Sedensky MM; Morgan PG
PLoS One; 2016; 11(1):e0148219. PubMed ID: 26824698
[TBL] [Abstract][Full Text] [Related]
11. Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome.
Piroli GG; Manuel AM; Clapper AC; Walla MD; Baatz JE; Palmiter RD; Quintana A; Frizzell N
Mol Cell Proteomics; 2016 Feb; 15(2):445-61. PubMed ID: 26450614
[TBL] [Abstract][Full Text] [Related]
12. Metabolic rescue ameliorates mitochondrial encephalo-cardiomyopathy in murine and human iPSC models of Leigh syndrome.
Yoon JY; Daneshgar N; Chu Y; Chen B; Hefti M; Vikram A; Irani K; Song LS; Brenner C; Abel ED; London B; Dai DF
Clin Transl Med; 2022 Jul; 12(7):e954. PubMed ID: 35872650
[TBL] [Abstract][Full Text] [Related]
13. Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice.
Miller HC; Louw R; Mereis M; Venter G; Boshoff JD; Mienie L; van Reenen M; Venter M; Lindeque JZ; Domínguez-Martínez A; Quintana A; van der Westhuizen FH
Mol Neurobiol; 2021 Jan; 58(1):243-262. PubMed ID: 32918239
[TBL] [Abstract][Full Text] [Related]
14. Ndufs4 KO mice: A model to study comorbid mood disorders associated with mitochondrial dysfunction.
van Rensburg DJ; Lindeque Z; Harvey BH; Steyn SF
Pharmacol Biochem Behav; 2024 Jan; 234():173689. PubMed ID: 38070656
[TBL] [Abstract][Full Text] [Related]
15. Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
van de Wal MAE; Adjobo-Hermans MJW; Keijer J; Schirris TJJ; Homberg JR; Wieckowski MR; Grefte S; van Schothorst EM; van Karnebeek C; Quintana A; Koopman WJH
Brain; 2022 Mar; 145(1):45-63. PubMed ID: 34849584
[TBL] [Abstract][Full Text] [Related]
16. Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4-/- mice.
Corrà S; Cerutti R; Balmaceda V; Viscomi C; Zeviani M
Brain; 2022 Oct; 145(10):3405-3414. PubMed ID: 36270002
[TBL] [Abstract][Full Text] [Related]
17. Iron status influences mitochondrial disease progression in Complex I-deficient mice.
Kelly CJ; Couch RK; Ha VT; Bodart CM; Wu J; Huff S; Herrel NT; Kim HD; Zimmermann AO; Shattuck J; Pan YC; Kaeberlein M; Grillo AS
Elife; 2023 Feb; 12():. PubMed ID: 36799301
[TBL] [Abstract][Full Text] [Related]
18. Elevated susceptibility to exogenous seizure triggers and impaired interneuron excitability in a mouse model of Leigh syndrome epilepsy.
Manning A; Han V; Stephens A; Wang R; Bush N; Bard M; Ramirez JM; Kalume F
Neurobiol Dis; 2023 Oct; 187():106288. PubMed ID: 37704057
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome.
Hanaford AR; Khanna A; James K; Truong V; Liao R; Chen Y; Mulholland M; Kayser EB; Watanabe K; Hsieh ES; Sedensky M; Morgan PG; Kalia V; Sarkar S; Johnson SC
Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12977. PubMed ID: 38680020
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
